Colitis induces calcitonin gene-related peptide expression and Akt activation in rat primary afferent pathways.
Previous study has shown that colitis-induced increases in calcitonin gene-related peptide (CGRP) immunoreactivity in bladder afferent neurons result in sensory cross-sensitization. To further determine the effects of colitis on CGRP expression in neurons other than bladder afferents, we examined and compared the levels of CGRP mRNA and immunoreactivity in the lumbosacral dorsal root ganglia (DRG) and spinal cord before and during colitis in rats. We also examined the changes in CGRP immunoreactivity in colonic afferent neurons during colitis. Results showed increases in CGRP mRNA levels in L1 (2.5-fold, p<0.05) and S1 DRG (1.9-2.4-fold, p<0.05). However, there were no changes in CGRP mRNA levels in L1 and S1 spinal cord during colitis. CGRP protein was significantly increased in L1 (2.5-fold increase, p<0.05) but decreased in S1 (50% decrease, p<0.05) colonic afferent neurons, which may reflect CGRP release from these neurons during colitis. In L1 spinal cord, colitis caused increases in the number of CGRP nerve fibers in the deep lamina region extending to the gray commissure where the number of phospho-Akt neurons was also increased. In S1 spinal cord, colitis caused the increases in the intensity of CGRP fibers in the regions of dorso-lateral tract, and caused the increases in the level of phospho-Akt in the superficial dorsal horn of the spinal cord. In spinal cord slice culture, exogenous CGRP increased the phosphorylation level of Akt but not the phosphorylation level of extracellular-signal regulated kinase ERK1/2 even though our previous studies showed that colitis increased the phosphorylation level of ERK1/2 in L1 and S1 spinal cord. These results suggest that CGRP is synthesized in the DRG and may transport to the spinal cord where it initiates signal transduction during colitis.
Department of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA 23298-0551, USA. lqiao2@vcu.edu
Li-Ya
LY
Qiao
John R
JR
Grider
D000818:Animals; D001369:Axons / Q000378:metabolism / Q000648:ultrastructure; D015740:Calcitonin Gene-Related Peptide / Q000235:genetics / Q000378:metabolism*; D003092:Colitis / Q000378:metabolism* / Q000503:physiopathology; D003106:Colon / Q000294:innervation* / Q000503:physiopathology; D004195:Disease Models, Animal; D005727:Ganglia, Spinal / Q000166:cytology / Q000378:metabolism; D008297:Male; D009619:Nociceptors / Q000166:cytology / Q000378:metabolism; D009924:Organ Culture Techniques; D010146:Pain / Q000378:metabolism / Q000503:physiopathology; D010766:Phosphorylation; D020671:Posterior Horn Cells / Q000166:cytology / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D011984:Sensory Receptor Cells / Q000166:cytology / Q000378:metabolism*; D013126:Spinal Nerve Roots / Q000166:cytology / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology; D017833:Visceral Afferents / Q000166:cytology / Q000378:metabolism*
D012333:RNA, Messenger; D051057:Proto-Oncogene Proteins c-akt; D015740:Calcitonin Gene-Related Peptide